LBP and Obesity: LGE, i.e. increased plasma levels of LPS and LPS-binding protein (LBP), is associated with obesity (75, 76), diabetes (75–77), cardiovascular diseases (CVD) (78, 79), gut microbiome dysbiosis (80), and periodontitis (81–84).